
|

|
OHF Funded Grants
Following is a chronological timeline, reviewing the continued progress of OHF research.
- 2009 Research Studies
- Grants
- Genetic Studies into atypical hyperoxaluria
Robert Kleta, MD, PhD, FASN, FACMG
University College London
London, United Kingdom
-
- Human KHGA: a novel target for the treatment of hyperoxaluria
W. Todd Lowther, PhD
Wake Forest University Health Sciences
Winston-Salem, North Carolina
-
- Towards the pharmacological treatment of primary hyperoxaluria: multiply-transformed CHO cells as a model system
Christopher J. Danpure, BSc PhD FMedSci
University College London
London, United Kingdom
-
- 2008 Research Studies
- Grants
- Molecular insights into Primary Hyperoxaluria Type 1
Carla Voltattorni, PhD
University of Verona
Verona, Italy
-
- Use of differential scanning fluorometry to identify ligands that stabilize AGT
Chandra Tucker, PhD
University of Duke
Durham, North Carolina
-
- Liver Cell Transplantation for Primary Hyperoxaluria
Namita Roy-Chowdury, PhD
Albert Einstein College of Medicine of Yeshiva University
Bronx, New York
-
- 2007 Research Studies
- Grants
- The Utility of Oxalobacter in Enhancing Enteric Oxalate Excretion in Primary Hyperoxaluria Type 1
Marguerite Hatch, PhD
University of Florida
Gainesville, Florida
-
- 2006 Research Studies
- Grants
- Identification and characterization of pharmacological chaperones for AGT
Chandra Tucker, PhD
Duke University
Durham, North Carolina
- Mutation-Specific Correction of Aberrant AGT Phenotypes in Transgenic Knockout Mice
Eduardo Salido, MD, PhD
Hospital Universitario Canarias / FRC Investigacion
Spain
-
- 2005 Research Studies
- Grants
- Regulation of Renal Epithelial Cell Surface Calcium Oxalate Crystal Binding Molecule
Vivek Kumar, PhD
Mayo Clinic
Rochester, Minnesota
- Hyaluronan and crystal retention
Carl F. Verkoelen, PhD
Erasmus Medical Center Rotterdam
Rotterdam, The Netherlands
-
- 2004 Research Studies
- Grants
- An investigation into the relationship between in vitro stone growth rate, oxalate and crystal size distribution
John P. Kavanagh, PhD
South Manchester University Hospitals Trust
Manchester, England
- Glycolate Oxidase Inhibition and the Treatment of Primary Hyperoxaluria Type 1
Ross Holmes, PhD
Wake Forest University Health Sciences
Winston-Salem, North Carolina
-
- 2003 Research Studies
- Grants
- Establish A Clinical Center for Primary Hyperoxaluria
Dawn S. Milliner, MD
Mayo Foundation
Rochester, Minnesota
- mRNA Expression of Renal Oxalate Transporters in Hyperoxaluria
Mike L. Green, PhD
University of Florida
Gainesville, Florida
-
- 2002 Research Studies
- Grants
- The Role of Tubule Epithelial Cell Pericellular Matrix Formation in the Retention of Calcium Oxalate Crystals
Carl Verkoelen, PhD
Erasmus Medical Center Rotterdam
Rotterdam, The Netherlands
- Towards a Better Understanding of the Metabolic Profile of the Hyperoxalurias
Gill Rumsby, PhD, MRCPath
University College London Hospitals
London, England
- AGT Structure, Folding and Stability: Drug-Induced AGT Stabilization as a Treatment for Primary Hyperoxaluria Type 1
Christopher Danpure, BSc, PhD
University College London
London, England
-
- 2001 Research Studies
- Grants
-
- Final Reports
-
- 2000 Research Studies
- Grants
-
-
- 1999 Research Studies
- Grants
-
-
- 1998 Research Studies
- Grants
-
-
- 1997 Research Studies
- Grants
-
-
Overview | Grant Applications | Funded Grants Patient Registry | Scientific Advisory Boards
Disclaimer: The OHF Foundation is not an accredited medical institution. It is a non-profit organization committed to raising funds for OHF research. While we are happy to share information from accredited medical professionals, none of the information in this section of the web site is the expressed interest of or a recommended course of action by the OHF Foundation.
|

|